PRNP and prion disease: A so-called neurotoxic peptide PrP(106-126), broadly used as a model of neurotoxicity in prion diseases, induced Egr-1 synthesis in primary cortical neurons just 30 min after the treatment (Gavín et al., 2005) suggesting a hypoxic cellular environment.